全文获取类型
收费全文 | 58091篇 |
免费 | 9698篇 |
国内免费 | 158篇 |
专业分类
耳鼻咽喉 | 865篇 |
儿科学 | 1812篇 |
妇产科学 | 1740篇 |
基础医学 | 5536篇 |
口腔科学 | 3349篇 |
临床医学 | 8623篇 |
内科学 | 11692篇 |
皮肤病学 | 1038篇 |
神经病学 | 5159篇 |
特种医学 | 2453篇 |
外国民族医学 | 3篇 |
外科学 | 8461篇 |
综合类 | 864篇 |
现状与发展 | 12篇 |
一般理论 | 44篇 |
预防医学 | 7252篇 |
眼科学 | 1266篇 |
药学 | 2961篇 |
1篇 | |
中国医学 | 52篇 |
肿瘤学 | 4764篇 |
出版年
2023年 | 1306篇 |
2022年 | 705篇 |
2021年 | 1380篇 |
2020年 | 1608篇 |
2019年 | 1184篇 |
2018年 | 2051篇 |
2017年 | 1859篇 |
2016年 | 2099篇 |
2015年 | 2194篇 |
2014年 | 2824篇 |
2013年 | 3649篇 |
2012年 | 2642篇 |
2011年 | 2603篇 |
2010年 | 2423篇 |
2009年 | 2847篇 |
2008年 | 2363篇 |
2007年 | 2172篇 |
2006年 | 2271篇 |
2005年 | 2034篇 |
2004年 | 1846篇 |
2003年 | 1689篇 |
2002年 | 1582篇 |
2001年 | 1574篇 |
2000年 | 1495篇 |
1999年 | 1414篇 |
1998年 | 925篇 |
1997年 | 866篇 |
1996年 | 892篇 |
1995年 | 687篇 |
1994年 | 633篇 |
1993年 | 584篇 |
1992年 | 988篇 |
1991年 | 937篇 |
1990年 | 909篇 |
1989年 | 809篇 |
1988年 | 816篇 |
1987年 | 769篇 |
1986年 | 703篇 |
1985年 | 754篇 |
1984年 | 611篇 |
1983年 | 508篇 |
1982年 | 350篇 |
1981年 | 350篇 |
1980年 | 301篇 |
1979年 | 508篇 |
1978年 | 384篇 |
1977年 | 300篇 |
1976年 | 304篇 |
1974年 | 313篇 |
1972年 | 287篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Christopher Teng JiaDe Yu Jesse Taylor Adam I. Rubin James R. Treat 《Pediatric dermatology》2019,36(5):697-701
Erosive pustular dermatosis of the scalp (EPDS) is an uncommon chronic inflammatory response to scalp trauma that usually resolves with cicatricial alopecia. It most commonly affects elderly patients with a history of actinic damage. Herein, we describe a 16‐year‐old girl with acrofacial dysostosis type 1 presenting after surgery with crusting purulent scalp lesions, whose clinical presentation and histopathologic findings were consistent with EPDS. A review of the literature on EPDS in children is also detailed. 相似文献
4.
5.
6.
7.
Maaike van Gerwen MD Naomi Alpert MS Raja Flores MD Emanuela Taioli MD PhD 《American journal of industrial medicine》2020,63(2):115-120
The association between asbestos exposure, mainly in occupational settings, and malignant mesothelioma has been well established; this has prompted several countries to establish mesothelioma epidemiologic surveillance programs often at the request of national agencies. This review compares currently existing mesothelioma registries worldwide to develop a concept model for a US real-time case capture mesothelioma registry. Five countries were identified with a mesothelioma specific registry, including Italy, France, UK, Australia, and South Korea. All, except the UK, used interviews to collect exposure data. Linkage with the national death index was available or was in future plans for all registries. The registries have limited information on treatment, quality of life, and other patient-centered outcomes such as symptoms and pain management. To thoroughly collect exposure data, “real-time” enrollment is preferable; to maximize the capture of mesothelioma cases, optimal coverage, and a simplified consent process are needed. 相似文献
8.
Chie Teramoto PHN RN MS Satoko Nagata PhD PHN RN Reiko Okamoto PhD PHN RN Ruriko Suzuki PHN RN MS Emiko Kishi PhD PHN RN Michie Nomura DSN PHN RN Noriko Jojima PHN RN MS Masumi Nishida PhD PHN RN Keiko Koide PhD PHN RN Emiko Kusano PhD PHN RN Saori Iwamoto PhD PHN RN Sachiyo Murashima PhD PHN RN 《Public health nursing (Boston, Mass.)》2015,32(6):654-661
9.
Weiyu Ye Anna Olsson-Brown Robert A. Watson Vincent T. F. Cheung Robert D. Morgan Isar Nassiri Rosalin Cooper Chelsea A. Taylor Umair Akbani Oliver Brain Rubeta N. Matin Nicholas Coupe Mark R. Middleton Mark Coles Joseph J. Sacco Miranda J. Payne Benjamin P. Fairfax 《British journal of cancer》2021,124(10):1661
Background Immune checkpoint blockers (ICBs) activate CD8+ T cells, eliciting both anti-cancer activity and immune-related adverse events (irAEs). The relationship of irAEs with baseline parameters and clinical outcome is unclear.Methods Retrospective evaluation of irAEs on survival was performed across primary (N = 144) and secondary (N = 211) independent cohorts of patients with metastatic melanoma receiving single agent (pembrolizumab/nivolumab—sICB) or combination (nivolumab and ipilimumab—cICB) checkpoint blockade. RNA from pre-treatment and post-treatment CD8+ T cells was sequenced and differential gene expression according to irAE development assessed.Results 58.3% of patients developed early irAEs and this was associated with longer progression-free (PFS) and overall survival (OS) across both cohorts (log-rank test, OS: P < 0.0001). Median survival for patients without irAEs was 16.6 months (95% CI: 10.9–33.4) versus not-reached (P = 2.8 × 10−6). Pre-treatment monocyte and neutrophil counts, but not BMI, were additional predictors of clinical outcome. Differential expression of numerous gene pathway members was observed in CD8+ T cells according to irAE development, and patients not developing irAEs demonstrating upregulated CXCR1 pre- and post-treatment.Conclusions Early irAE development post-ICB is associated with favourable survival in MM. Development of irAEs is coupled to expression of numerous gene pathways, suggesting irAE development in-part reflects baseline immune activation.Subject terms: Immunotherapy, Melanoma 相似文献
10.